Isaac V. Faustino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Isaac V. Faustino has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Ambrose Hon-Wai Wong
Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, USA
4 shared publications - Richard Andrew Taylor
Department of Emergency Medicine University of Virginia Charlottesville Virginia USA
4 shared publications Bidisha Nath
Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, USA
3 shared publications- Edward R. Melnick
Department of Emergency Medicine, Yale School of Medicine, New Haven, CT
3 shared publications Rebekah Heckmann
Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, USA
3 shared publications- Alexandria Brackett
Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, United States
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0355397
Children in child protective services custody experience higher risk of intramuscular medication and physical restraints in a pediatric emergency department
Objective: To assess the association between child protective services (CPS) involvement and the risk and timing of intramuscular (IM) medication or physical restraint use in pediatric patients presenting to the emergency department (ED) with behavioral health concerns. Methods: An electronic health record dataset spanning January 2021 to October 2023 was retrospectively analyzed. Individual cumulative incidence plots and Cox regression models were created to model the risk and risk rate of receiving either IM medication or being physically restrained by different levels of CPS involvement. Cox regression models were adjusted for age, legal sex, and race and ethnicity. Results: We analyzed 6257 behavioral health encounters. Children in CPS custody had the highest cumulative incidence of receiving IM medication or being physically restrained compared to children with a new CPS report filed or children without any CPS involvement after 72 hours (IM medication: 17%, 6%, 5% respectively, p < 0.001, physical restraints: 8%, 4%, 3% respectively, p < 0.001). Compared to children without CPS involvement, children in CPS custody had a significantly higher risk rate of receiving IM medications (adjusted hazard ratio (aHR) 1.79, 95% Confidence Interval (CI) 1.01–3.18, p = 0.046), and physical restraints (aHR 2.71, 95% CI 1.35–5.43 p = 0.005). Conclusion: Children in CPS custody had a higher risk of receiving IM medication and being physically restrained during behavioral health encounters in a pediatric ED. Further work should focus on understanding the causal mechanisms and designing interventions that maximize optimal health outcomes for vulnerable children experiencing behavioral health emergencies.
- 12 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0355397
Open AccessChildren in child protective services custody experience higher risk of intramuscular medication and physical restraints in a pediatric emergency department
Objective: To assess the association between child protective services (CPS) involvement and the risk and timing of intramuscular (IM) medication or physical restraint use in pediatric patients presenting to the emergency department (ED) with behavioral health concerns. Methods: An electronic health record dataset spanning January 2021 to October 2023 was retrospectively analyzed. Individual cumulative incidence plots and Cox regression models were created to model the risk and risk rate of receiving either IM medication or being physically restrained by different levels of CPS involvement. Cox regression models were adjusted for age, legal sex, and race and ethnicity. Results: We analyzed 6257 behavioral health encounters. Children in CPS custody had the highest cumulative incidence of receiving IM medication or being physically restrained compared to children with a new CPS report filed or children without any CPS involvement after 72 hours (IM medication: 17%, 6%, 5% respectively, p < 0.001, physical restraints: 8%, 4%, 3% respectively, p < 0.001). Compared to children without CPS involvement, children in CPS custody had a significantly higher risk rate of receiving IM medications (adjusted hazard ratio (aHR) 1.79, 95% Confidence Interval (CI) 1.01–3.18, p = 0.046), and physical restraints (aHR 2.71, 95% CI 1.35–5.43 p = 0.005). Conclusion: Children in CPS custody had a higher risk of receiving IM medication and being physically restrained during behavioral health encounters in a pediatric ED. Further work should focus on understanding the causal mechanisms and designing interventions that maximize optimal health outcomes for vulnerable children experiencing behavioral health emergencies.
- 6 July 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (8) , 2326-2337
Assigning Probable Dementia Status Using Routinely Collected Electronic Health Record Data
Introduction: More than half of older adults with Alzheimer's Disease and Related Dementias (ADRD) are undiagnosed, limiting timely access to person‐centered care. Therefore, clinicians, researchers, and population health managers need scalable, reproducible approaches to monitor both prevalence and diagnostic gaps. We evaluated whether a decision‐analytic modeling framework can translate a limited number of clinician‐adjudicated cases of ADRD into a probabilistic computational phenotype for accurate, population‐level assignments of probable ADRD in the emergency department (ED) setting using routinely collected electronic health record (EHR) data. Methods: Retrospective cohort study of 5000 adults aged ≥ 65 years from nine EDs within a large integrated health system (2014–2022). We randomly selected 500 individuals for clinician adjudication of dementia status (reference cohort), reserving the remaining 4500 as a phenotyping cohort. We developed the phenotype as a logistic regression model trained on adjudicated cases, embedding pattern‐mixture multiple imputation to address information bias. We applied decision‐curve analysis to evaluate clinical utility across probabilistic thresholds. We applied the phenotype to assign dementia status to 4500 unadjudicated patients and compared clinical characteristics to adjudicated cases. Results: The mean (SD) age was 77.4 (9.0) years; 55.4% were women; 102 individuals (20.4%) had clinician‐adjudicated ADRD. The model demonstrated good discrimination (AUROC 0.87; 95% CI 0.82–0.91). Decision‐curve analysis revealed net clinical benefit across examined thresholds (predicted probabilities 12%–32%), identifying an additional 16–18 probable ADRD cases per 100 older adults. Among those without ADRD‐related diagnosis codes, net benefit ranged from 8 to 13 additional correct identifications per 100. Phenotype‐assigned cases closely resembled clinician‐adjudicated cases (standardized mean differences ≤ 0.20). Conclusions: A probabilistic computational phenotype derived from routinely collected EHR data accurately reproduced clinician‐adjudicated ADRD status and demonstrated net clinical benefit, including among ED patients whose ADRD was not captured by diagnosis codes. Adoption of this replicable framework may enable healthcare organizations to strengthen ADRD surveillance and reduce underdiagnosis.
- 6 July 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (8) , 2326-2337
Assigning Probable Dementia Status Using Routinely Collected Electronic Health Record Data
Introduction: More than half of older adults with Alzheimer's Disease and Related Dementias (ADRD) are undiagnosed, limiting timely access to person‐centered care. Therefore, clinicians, researchers, and population health managers need scalable, reproducible approaches to monitor both prevalence and diagnostic gaps. We evaluated whether a decision‐analytic modeling framework can translate a limited number of clinician‐adjudicated cases of ADRD into a probabilistic computational phenotype for accurate, population‐level assignments of probable ADRD in the emergency department (ED) setting using routinely collected electronic health record (EHR) data. Methods: Retrospective cohort study of 5000 adults aged ≥ 65 years from nine EDs within a large integrated health system (2014–2022). We randomly selected 500 individuals for clinician adjudication of dementia status (reference cohort), reserving the remaining 4500 as a phenotyping cohort. We developed the phenotype as a logistic regression model trained on adjudicated cases, embedding pattern‐mixture multiple imputation to address information bias. We applied decision‐curve analysis to evaluate clinical utility across probabilistic thresholds. We applied the phenotype to assign dementia status to 4500 unadjudicated patients and compared clinical characteristics to adjudicated cases. Results: The mean (SD) age was 77.4 (9.0) years; 55.4% were women; 102 individuals (20.4%) had clinician‐adjudicated ADRD. The model demonstrated good discrimination (AUROC 0.87; 95% CI 0.82–0.91). Decision‐curve analysis revealed net clinical benefit across examined thresholds (predicted probabilities 12%–32%), identifying an additional 16–18 probable ADRD cases per 100 older adults. Among those without ADRD‐related diagnosis codes, net benefit ranged from 8 to 13 additional correct identifications per 100. Phenotype‐assigned cases closely resembled clinician‐adjudicated cases (standardized mean differences ≤ 0.20). Conclusions: A probabilistic computational phenotype derived from routinely collected EHR data accurately reproduced clinician‐adjudicated ADRD status and demonstrated net clinical benefit, including among ED patients whose ADRD was not captured by diagnosis codes. Adoption of this replicable framework may enable healthcare organizations to strengthen ADRD surveillance and reduce underdiagnosis.
- Open Access
- 13 March 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5 (1) , e93250
Correction: Real-World Evidence Synthesis of Digital Scribes Using Ambient Listening and Generative Artificial Intelligence for Clinician Documentation Workflows: Rapid Review
- 13 March 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5 (1) , e93250
Open AccessCorrection: Real-World Evidence Synthesis of Digital Scribes Using Ambient Listening and Generative Artificial Intelligence for Clinician Documentation Workflows: Rapid Review
- Top Cited PapersOpen Access
- 10 October 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e76743
Real-World Evidence Synthesis of Digital Scribes Using Ambient Listening and Generative Artificial Intelligence for Clinician Documentation Workflows: Rapid Review
Background: As physicians spend up to twice as much time on electronic health record tasks as on direct patient care, digital scribes have emerged as a promising solution to restore patient-clinician communication and reduce documentation burden—making it essential to study their real-world impact on clinical workflows, efficiency, and satisfaction. Objective: This study aimed to synthesize evidence on clinician efficiency, user satisfaction, quality, and practical barriers associated with the use of digital scribes using ambient listening and generative artificial intelligence (AI) in real-world clinical settings. Methods: A rapid review was conducted to evaluate the real-world evidence of digital scribes using ambient listening and generative AI in clinical practice from 2014 to 2024. Data were collected from Ovid MEDLINE, Embase, Web of Science–Core Collection, Cochrane CENTRAL and Reviews, and PubMed Central. Predefined eligibility criteria focused on studies addressing clinical implementation, excluding those centered solely on technical development or model validation. The findings of each study were synthesized and analyzed through the QUEST human evaluation framework for quality and safety and the Systems Engineering Initiative for Patient Safety (SEIPS) 3.0 model to assess integration into clinicians’ workflows and experience. Results: Of the 1450 studies identified, 6 met the inclusion criteria. These studies included an observational study, a case report, a peer-matched cohort study, and survey-based assessments conducted across academic health systems, community settings, and outpatient practices. The major themes noted were as follows: (1) they decreased self-reported documentation times, with associated increased length of notes; (2) physician burnout measured using standardized scales was unaffected, but physician engagement improved; (3) physician productivity, assessed via billing metrics, was unchanged; and (4) the studies fell short when compared to standardized frameworks. Conclusions: Digital scribes show promise in reducing documentation burden and enhancing clinician satisfaction, thereby supporting workflow efficiency. However, the currently available evidence is sparse. Future real-world, multifaceted studies are needed before AI scribes can be recommended unequivocally.
- 10 October 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e76743
Top Cited PapersOpen AccessReal-World Evidence Synthesis of Digital Scribes Using Ambient Listening and Generative Artificial Intelligence for Clinician Documentation Workflows: Rapid Review
Background: As physicians spend up to twice as much time on electronic health record tasks as on direct patient care, digital scribes have emerged as a promising solution to restore patient-clinician communication and reduce documentation burden—making it essential to study their real-world impact on clinical workflows, efficiency, and satisfaction. Objective: This study aimed to synthesize evidence on clinician efficiency, user satisfaction, quality, and practical barriers associated with the use of digital scribes using ambient listening and generative artificial intelligence (AI) in real-world clinical settings. Methods: A rapid review was conducted to evaluate the real-world evidence of digital scribes using ambient listening and generative AI in clinical practice from 2014 to 2024. Data were collected from Ovid MEDLINE, Embase, Web of Science–Core Collection, Cochrane CENTRAL and Reviews, and PubMed Central. Predefined eligibility criteria focused on studies addressing clinical implementation, excluding those centered solely on technical development or model validation. The findings of each study were synthesized and analyzed through the QUEST human evaluation framework for quality and safety and the Systems Engineering Initiative for Patient Safety (SEIPS) 3.0 model to assess integration into clinicians’ workflows and experience. Results: Of the 1450 studies identified, 6 met the inclusion criteria. These studies included an observational study, a case report, a peer-matched cohort study, and survey-based assessments conducted across academic health systems, community settings, and outpatient practices. The major themes noted were as follows: (1) they decreased self-reported documentation times, with associated increased length of notes; (2) physician burnout measured using standardized scales was unaffected, but physician engagement improved; (3) physician productivity, assessed via billing metrics, was unchanged; and (4) the studies fell short when compared to standardized frameworks. Conclusions: Digital scribes show promise in reducing documentation burden and enhancing clinician satisfaction, thereby supporting workflow efficiency. However, the currently available evidence is sparse. Future real-world, multifaceted studies are needed before AI scribes can be recommended unequivocally.
- Open Access
Peer support enhanced behavioural crisis response teams in the emergency department: protocol for a stepped-wedge cluster-randomised controlled trial
Introduction Despite expert recommendations to prioritise non-invasive and patient-centred approaches for behavioural crisis management, physical restraints are commonly used in the emergency department (ED). Patients describe the restraint process as coercive and dehumanising. The use of peer support workers, who are individuals with lived experience of mental illness and behavioural conditions, has shown positive patient outcomes when assisting individuals experiencing behavioural crises. However, there is limited evidence of the implementation of such an approach in the ED setting. The goal of this study is to evaluate if the implementation of a Peer support enhanced Agitation Crisis response Team (PACT) for behavioural crisis management in the ED is more effective than usual care to reduce restraint use and improve outcomes among patients presenting to the ED with behavioural crises. Methods and analysis We will first conduct a stakeholder-informed needs assessment to codesign the protocol and then train staff and peers in PACT intervention readiness. Next, a stepped-wedge, cluster-randomised controlled trial will be conducted over 3 years at five ED sites across a healthcare system in the Northeast USA. The PACT intervention will integrate peer delivery of trauma-informed care within a structured, interprofessional, team-based response protocol for behavioural crisis management. The primary outcome is the rate of physical restraint and/or sedation use. The secondary outcome is the level of patient agitation during the ED visit. Analyses of primary and secondary outcomes will be conducted using generalised linear mixed models. Ethics and dissemination This protocol has been approved by the Yale University Human Investigation Committee (protocol number 2000037554). The study is deemed minimal risk and has been granted a waiver of consent for trial participants. However, verbal consent will be obtained for a subset of patients receiving follow-up data collection. Results will be disseminated through publications in open-access, peer-reviewed journals, via scientific presentations, or through direct mail notifications. Trial registration number Clinicaltrials.gov: NCT06556069.
Open AccessPeer support enhanced behavioural crisis response teams in the emergency department: protocol for a stepped-wedge cluster-randomised controlled trial
Introduction Despite expert recommendations to prioritise non-invasive and patient-centred approaches for behavioural crisis management, physical restraints are commonly used in the emergency department (ED). Patients describe the restraint process as coercive and dehumanising. The use of peer support workers, who are individuals with lived experience of mental illness and behavioural conditions, has shown positive patient outcomes when assisting individuals experiencing behavioural crises. However, there is limited evidence of the implementation of such an approach in the ED setting. The goal of this study is to evaluate if the implementation of a Peer support enhanced Agitation Crisis response Team (PACT) for behavioural crisis management in the ED is more effective than usual care to reduce restraint use and improve outcomes among patients presenting to the ED with behavioural crises. Methods and analysis We will first conduct a stakeholder-informed needs assessment to codesign the protocol and then train staff and peers in PACT intervention readiness. Next, a stepped-wedge, cluster-randomised controlled trial will be conducted over 3 years at five ED sites across a healthcare system in the Northeast USA. The PACT intervention will integrate peer delivery of trauma-informed care within a structured, interprofessional, team-based response protocol for behavioural crisis management. The primary outcome is the rate of physical restraint and/or sedation use. The secondary outcome is the level of patient agitation during the ED visit. Analyses of primary and secondary outcomes will be conducted using generalised linear mixed models. Ethics and dissemination This protocol has been approved by the Yale University Human Investigation Committee (protocol number 2000037554). The study is deemed minimal risk and has been granted a waiver of consent for trial participants. However, verbal consent will be obtained for a subset of patients receiving follow-up data collection. Results will be disseminated through publications in open-access, peer-reviewed journals, via scientific presentations, or through direct mail notifications. Trial registration number Clinicaltrials.gov: NCT06556069.
- Top Cited Papers
- 27 February 2025
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 2 (3)
Impact of Artificial Intelligence–Based Triage Decision Support on Emergency Department Care
- 27 February 2025
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 2 (3)
Top Cited PapersImpact of Artificial Intelligence–Based Triage Decision Support on Emergency Department Care
- 13 February 2025
- Published by Wiley in Academic Emergency Medicine
- Vol. 32 (8) , 836-847
Association between patient primary language, physical restraints, and intramuscular sedation in the emergency department
Background: Despite the importance of effective communication during verbal de‐escalation, research regarding patient primary language during management of agitation symptoms is limited. We evaluated associations between patient primary language and use of physical restraints and intramuscular (IM) sedation in the emergency department (ED).Methods: This was a retrospective cohort analysis evaluating physical restraint and IM sedation characteristics using electronic medical records from 13 EDs affiliated with a large regional health care network located in the northeast United States. Data were collected for ED visits from 2013 to 2023 for all adult patients ages 18 and older. We performed logistic regression models using the presence of physical restraint and IM sedation orders as primary outcomes, adjusting for patient primary language, sex assigned at birth, age, race and ethnicity, and chief complaints.Results: In our analysis of 3,406,474 visits, 3,086,512 included English speakers, 250,912 included Spanish speakers, 9,057 included Portuguese speakers, 6,616 included Arabic speakers, 6,425 included Italian speakers, 39,303 included other language speakers, and 7,649 included unknown language speakers; 18,546 visits included use of physical restraints and 48,277 visits included use of IM sedation. After demographic and clinical characteristics were adjusted for, visits with Spanish‐ and Portuguese‐speaking patients had a reduced likelihood of physical restraints and IM sedation compared to English speakers, with adjusted odds ratios (95% confidence intervals) of 0.70 (0.65–0.76) and 0.82 (0.79–0.87) for Spanish speakers and 0.39 (0.20–0.68) and 0.84 (0.66–1.05) for Portuguese speakers, respectively.Conclusions: ED visits with Spanish‐ and Portuguese‐speaking patients were found to have lower odds of physical restraints and IM sedation, while Arabic, Italian, other, and unknown language–speaking patients were found to have higher odds. Factors contributing to linguistic differences in physical restraint and IM sedation use, such as cultural interpretations of behavior, quality of clinical interactions, and patient–clinician communication strategies, merit further investigation.
- 13 February 2025
- Published by Wiley in Academic Emergency Medicine
- Vol. 32 (8) , 836-847
Association between patient primary language, physical restraints, and intramuscular sedation in the emergency department
Background: Despite the importance of effective communication during verbal de‐escalation, research regarding patient primary language during management of agitation symptoms is limited. We evaluated associations between patient primary language and use of physical restraints and intramuscular (IM) sedation in the emergency department (ED).Methods: This was a retrospective cohort analysis evaluating physical restraint and IM sedation characteristics using electronic medical records from 13 EDs affiliated with a large regional health care network located in the northeast United States. Data were collected for ED visits from 2013 to 2023 for all adult patients ages 18 and older. We performed logistic regression models using the presence of physical restraint and IM sedation orders as primary outcomes, adjusting for patient primary language, sex assigned at birth, age, race and ethnicity, and chief complaints.Results: In our analysis of 3,406,474 visits, 3,086,512 included English speakers, 250,912 included Spanish speakers, 9,057 included Portuguese speakers, 6,616 included Arabic speakers, 6,425 included Italian speakers, 39,303 included other language speakers, and 7,649 included unknown language speakers; 18,546 visits included use of physical restraints and 48,277 visits included use of IM sedation. After demographic and clinical characteristics were adjusted for, visits with Spanish‐ and Portuguese‐speaking patients had a reduced likelihood of physical restraints and IM sedation compared to English speakers, with adjusted odds ratios (95% confidence intervals) of 0.70 (0.65–0.76) and 0.82 (0.79–0.87) for Spanish speakers and 0.39 (0.20–0.68) and 0.84 (0.66–1.05) for Portuguese speakers, respectively.Conclusions: ED visits with Spanish‐ and Portuguese‐speaking patients were found to have lower odds of physical restraints and IM sedation, while Arabic, Italian, other, and unknown language–speaking patients were found to have higher odds. Factors contributing to linguistic differences in physical restraint and IM sedation use, such as cultural interpretations of behavior, quality of clinical interactions, and patient–clinician communication strategies, merit further investigation.
- Open Access
Formative evaluation of an emergency department clinical decision support system for agitation symptoms: a study protocol
Introduction The burden of mental health-related visits to emergency departments (EDs) is growing, and agitation episodes are prevalent with such visits. Best practice guidance from experts recommends early assessment of at-risk populations and pre-emptive intervention using de-escalation techniques to prevent agitation. Time pressure, fluctuating work demands, and other systems-related factors pose challenges to efficient decision-making and adoption of best practice recommendations during an unfolding behavioural crisis. As such, we propose to design, develop and evaluate a computerised clinical decision support (CDS) system, Early Detection and Treatment to Reduce Events with Agitation Tool (ED-TREAT). We aim to identify patients at risk of agitation and guide ED clinicians through appropriate risk assessment and timely interventions to prevent agitation with a goal of minimising restraint use and improving patient experience and outcomes. Methods and analysis This study describes the formative evaluation of the health record embedded CDS tool. Under aim 1, the study will collect qualitative data to design and develop ED-TREAT using a contextual design approach and an iterative user-centred design process. Participants will include potential CDS users, that is, ED physicians, nurses, technicians, as well as patients with lived experience of restraint use for behavioural crisis management during an ED visit. We will use purposive sampling to ensure the full spectrum of perspectives until we reach thematic saturation. Next, under aim 2, the study will conduct a pilot, randomised controlled trial of ED-TREAT at two adult ED sites in a regional health system in the Northeast USA to evaluate the feasibility, fidelity and bedside acceptability of ED-TREAT. We aim to recruit a total of at least 26 eligible subjects under the pilot trial. Ethics and dissemination Ethical approval by the Yale University Human Investigation Committee was obtained in 2021 (HIC# 2000030893 and 2000030906). All participants will provide informed verbal consent prior to being enrolled in the study. Results will be disseminated through publications in open-access, peer-reviewed journals, via scientific presentations or through direct email notifications. Trial registration number NCT04959279; Pre-results.
Open AccessFormative evaluation of an emergency department clinical decision support system for agitation symptoms: a study protocol
Introduction The burden of mental health-related visits to emergency departments (EDs) is growing, and agitation episodes are prevalent with such visits. Best practice guidance from experts recommends early assessment of at-risk populations and pre-emptive intervention using de-escalation techniques to prevent agitation. Time pressure, fluctuating work demands, and other systems-related factors pose challenges to efficient decision-making and adoption of best practice recommendations during an unfolding behavioural crisis. As such, we propose to design, develop and evaluate a computerised clinical decision support (CDS) system, Early Detection and Treatment to Reduce Events with Agitation Tool (ED-TREAT). We aim to identify patients at risk of agitation and guide ED clinicians through appropriate risk assessment and timely interventions to prevent agitation with a goal of minimising restraint use and improving patient experience and outcomes. Methods and analysis This study describes the formative evaluation of the health record embedded CDS tool. Under aim 1, the study will collect qualitative data to design and develop ED-TREAT using a contextual design approach and an iterative user-centred design process. Participants will include potential CDS users, that is, ED physicians, nurses, technicians, as well as patients with lived experience of restraint use for behavioural crisis management during an ED visit. We will use purposive sampling to ensure the full spectrum of perspectives until we reach thematic saturation. Next, under aim 2, the study will conduct a pilot, randomised controlled trial of ED-TREAT at two adult ED sites in a regional health system in the Northeast USA to evaluate the feasibility, fidelity and bedside acceptability of ED-TREAT. We aim to recruit a total of at least 26 eligible subjects under the pilot trial. Ethics and dissemination Ethical approval by the Yale University Human Investigation Committee was obtained in 2021 (HIC# 2000030893 and 2000030906). All participants will provide informed verbal consent prior to being enrolled in the study. Results will be disseminated through publications in open-access, peer-reviewed journals, via scientific presentations or through direct email notifications. Trial registration number NCT04959279; Pre-results.
- Open Access
Isogenic hiPSC models of Turner syndrome development reveal shared roles of inactive X and Y in the human cranial neural crest network
SUMMARY: Modeling the developmental etiology of viable human aneuploidy can be challenging in rodents due to syntenic boundaries, or primate-specific biology. In humans, monosomy-X (45,X) causes Turner syndrome (TS), altering craniofacial, skeletal, endocrine, and cardiovascular development, which in contrast remain unaffected in 39,X-mice. To learn how human monosomy-X may impact early embryonic development, we turned to human 45,X and isogenic euploid induced pluripotent stem cells (hiPSCs) from male and female mosaic donors. Because neural crest (NC) derived cell types are hypothesized to underpin craniofacial and cardiovascular changes in TS, we performed a highly-powered differential expression study on hiPSC-derived anterior neural crest cells (NCCs). Across three independent isogenic panels, 45,X NCCs show impaired acquisition of PAX7 + SOX10 + markers, and disrupted expression of other NCC-specific genes, relative to their isogenic euploid controls. In particular, 45,X NCCs increase cholesterol biosynthesis genes while reducing transcripts that feature 5’ terminal oligopyrimidine (TOP) motifs, including those of ribosomal protein and nuclear-encoded mitochondrial genes. Such metabolic pathways are also over-represented in weighted co-expression gene modules that are preserved in monogenic neurocristopathy. Importantly, these gene modules are also significantly enriched in 28% of all TS-associated terms of the human phenotype ontology. Our analysis identifies specific sex-linked genes that are expressed from two copies in euploid males and females alike and qualify as candidate haploinsufficient drivers of TS phenotypes in NC-derived lineages. This study demonstrates that isogenic hiPSC-derived NCC panels representing monosomy-X can serve as a powerful model of early NC development in TS and inform new hypotheses towards its etiology.
Open AccessIsogenic hiPSC models of Turner syndrome development reveal shared roles of inactive X and Y in the human cranial neural crest network
SUMMARY: Modeling the developmental etiology of viable human aneuploidy can be challenging in rodents due to syntenic boundaries, or primate-specific biology. In humans, monosomy-X (45,X) causes Turner syndrome (TS), altering craniofacial, skeletal, endocrine, and cardiovascular development, which in contrast remain unaffected in 39,X-mice. To learn how human monosomy-X may impact early embryonic development, we turned to human 45,X and isogenic euploid induced pluripotent stem cells (hiPSCs) from male and female mosaic donors. Because neural crest (NC) derived cell types are hypothesized to underpin craniofacial and cardiovascular changes in TS, we performed a highly-powered differential expression study on hiPSC-derived anterior neural crest cells (NCCs). Across three independent isogenic panels, 45,X NCCs show impaired acquisition of PAX7 + SOX10 + markers, and disrupted expression of other NCC-specific genes, relative to their isogenic euploid controls. In particular, 45,X NCCs increase cholesterol biosynthesis genes while reducing transcripts that feature 5’ terminal oligopyrimidine (TOP) motifs, including those of ribosomal protein and nuclear-encoded mitochondrial genes. Such metabolic pathways are also over-represented in weighted co-expression gene modules that are preserved in monogenic neurocristopathy. Importantly, these gene modules are also significantly enriched in 28% of all TS-associated terms of the human phenotype ontology. Our analysis identifies specific sex-linked genes that are expressed from two copies in euploid males and females alike and qualify as candidate haploinsufficient drivers of TS phenotypes in NC-derived lineages. This study demonstrates that isogenic hiPSC-derived NCC panels representing monosomy-X can serve as a powerful model of early NC development in TS and inform new hypotheses towards its etiology.
- Open Access
Monosomy X in isogenic human iPSC-derived trophoblast model impacts expression modules preserved in human placenta
SUMMARY/ Mammalian sex chromosomes encode homologous X/Y gene pairs that were retained on the male Y and escape X chromosome inactivation (XCI) in females. Inferred to reflect X/Y-pair dosage sensitivity, monosomy X is a leading cause of miscarriage in humans with near full penetrance. This phenotype is shared with many other mammals but not the mouse, which offers sophisticated genetic tools to generate sex chromosomal aneuploidy but also tolerates its developmental impact. To address this critical gap, we generated X-monosomic human induced pluripotent stem cells (hiPSCs) alongside otherwise isogenic euploid controls from male and female mosaic samples. Phased genomic variants of these hiPSC panels enable systematic investigation of X/Y dosage-sensitive features using in vitro models of human development. Here, we demonstrate the utility of these validated hiPSC lines to test how X/Y-linked gene dosage impacts a widely-used model for the human syncytiotrophoblast. While these isogenic panels trigger a GATA2/3 and TFAP2A/C -driven trophoblast gene circuit irrespective of karyotype, differential expression implicates monosomy X in altered levels of placental genes, and in secretion of placental growth factor (PlGF) and human chorionic gonadotropin (hCG). Remarkably, weighted gene co-expression network modules that significantly reflect these changes are also preserved in first-trimester chorionic villi and term placenta. Our results suggest monosomy X may skew trophoblast cell type composition, and that the pseudoautosomal region likely plays a key role in these changes, which may facilitate prioritization of haploinsufficient drivers of 45,X extra-embryonic phenotypes.
Open AccessMonosomy X in isogenic human iPSC-derived trophoblast model impacts expression modules preserved in human placenta
SUMMARY/ Mammalian sex chromosomes encode homologous X/Y gene pairs that were retained on the male Y and escape X chromosome inactivation (XCI) in females. Inferred to reflect X/Y-pair dosage sensitivity, monosomy X is a leading cause of miscarriage in humans with near full penetrance. This phenotype is shared with many other mammals but not the mouse, which offers sophisticated genetic tools to generate sex chromosomal aneuploidy but also tolerates its developmental impact. To address this critical gap, we generated X-monosomic human induced pluripotent stem cells (hiPSCs) alongside otherwise isogenic euploid controls from male and female mosaic samples. Phased genomic variants of these hiPSC panels enable systematic investigation of X/Y dosage-sensitive features using in vitro models of human development. Here, we demonstrate the utility of these validated hiPSC lines to test how X/Y-linked gene dosage impacts a widely-used model for the human syncytiotrophoblast. While these isogenic panels trigger a GATA2/3 and TFAP2A/C -driven trophoblast gene circuit irrespective of karyotype, differential expression implicates monosomy X in altered levels of placental genes, and in secretion of placental growth factor (PlGF) and human chorionic gonadotropin (hCG). Remarkably, weighted gene co-expression network modules that significantly reflect these changes are also preserved in first-trimester chorionic villi and term placenta. Our results suggest monosomy X may skew trophoblast cell type composition, and that the pseudoautosomal region likely plays a key role in these changes, which may facilitate prioritization of haploinsufficient drivers of 45,X extra-embryonic phenotypes.